Strong growth expected in Asian generics and biopharma markets

摘要

Strong market growth is predicted within the generics and biopharma industries in Asia, according to a report by consultancy firm, Frost & Sullivan. The growth is expected as the effects of the recession retreat, and companies look to broaden their reach and acquire new assets.